Granted Patent
B2
US 10,800,725 · App. 13/821,787 · Granted Oct 13, 2020
Arylpropionyl-triketone antibacterial agents
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention provides a compound of formula (I): or a salt thereof, wherein R 1 -R 5 have any of the values described in the specification, as well as compositions comprising a compound of formula (I). The compounds are useful as RNA polymerase inhibitors and antibacterial agents.
Claims (3)
1. A compound having the following structure:
or a tautomer thereof, or a pharmaceutically acceptable salt thereof.
2. A composition comprising the compound of claim 1 or a tautomer thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle.
Assignments (1)
CONFIRMATORY LICENSE
Recorded May 21, 2013
From: RUTGERS THE STATE UNIV NEW BRUNSWICK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030454/0836 →
Continuity (3)
Provisional Application
61381117
· Sep 9, 2010
Provisional Application
61498385
· Jun 17, 2011